2-Fluoro-5-formylbenzonitrile: A Key Pharmaceutical Intermediate for PARP Inhibitors
The pharmaceutical industry continuously seeks advanced chemical intermediates to develop novel therapeutics that target complex diseases. Among these, molecules that enable the synthesis of targeted therapies, such as PARP inhibitors, are of significant interest. These inhibitors play a crucial role in cancer treatment by blocking specific enzymes involved in DNA repair, thereby preventing cancer cells from multiplying.
2-Fluoro-5-formylbenzonitrile (CAS 218301-22-5) stands out as a pivotal intermediate in the synthesis of several potent PARP inhibitors, most notably Olaparib. Olaparib is a breakthrough medication used to treat various cancers, including ovarian, breast, and pancreatic cancers, particularly those with BRCA gene mutations. The precise structure of 2-Fluoro-5-formylbenzonitrile provides the necessary functional groups and aromatic framework required for the efficient construction of these complex pharmacological agents.
For pharmaceutical researchers and procurement specialists, the consistent availability of high-quality pharmaceutical intermediates is paramount. The synthesis of APIs demands intermediates with exceptionally high purity, often exceeding 99%, to ensure the safety and efficacy of the final drug product. Sourcing challenges can arise from inconsistent quality, limited supply, or unreliable manufacturers. This is where partnering with a dedicated 218301-22-5 chemical supplier becomes critical.
When looking to buy 2-Fluoro-5-formylbenzonitrile, pharmaceutical companies often turn to experienced manufacturers in China, which offers a competitive edge in terms of cost and production capacity. A reliable China manufacturer can provide the scalability needed for both clinical trial material production and large-scale commercial manufacturing. It is essential to select a supplier that not only guarantees high purity but also adheres to stringent quality management systems, providing comprehensive documentation like Certificates of Analysis (CoAs) and ensuring regulatory compliance.
The ability to purchase 2-Fluoro-5-formylbenzonitrile at a competitive price directly from a manufacturer can significantly impact the overall cost of drug development and production. By establishing a direct relationship, companies can gain better control over their supply chain and ensure timely delivery, which is crucial for meeting project timelines and patient needs.
In summary, 2-Fluoro-5-formylbenzonitrile is an indispensable intermediate for the advancement of targeted cancer therapies. Pharmaceutical professionals seeking to secure a stable, high-purity supply for their API synthesis should prioritize working with established manufacturers and suppliers. As a leading provider of this critical chemical, we are dedicated to supporting your research and development efforts with exceptional quality and reliable service. Contact us for a quote and to discuss your specific requirements for this essential pharmaceutical building block.
Perspectives & Insights
Future Origin 2025
“Contact us for a quote and to discuss your specific requirements for this essential pharmaceutical building block.”
Core Analyst 01
“The pharmaceutical industry continuously seeks advanced chemical intermediates to develop novel therapeutics that target complex diseases.”
Silicon Seeker One
“Among these, molecules that enable the synthesis of targeted therapies, such as PARP inhibitors, are of significant interest.”